Structural Biology of Amyloid Disease
Structural Biology of Amyloid Disease
批准号:
7486285
负责人:
DAVID EISENBERG
金额:
$43.27万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-05-31
关键词:
Alzheimer&aposs DiseaseAmino Acid SequenceAmino AcidsAmyloidAmyloid FibrilsAmyloidosisAmyotrophic Lateral SclerosisArchitectureBehaviorCollaborationsComputational BiologyCrystallographyDiagnosticDiseaseFaceFoundationsGlutamineGrantHuntington DiseaseLearningLengthLiteratureMethodsMutateNeurodegenerative DisordersNon-Insulin-Dependent Diabetes MellitusNumbersPaperParentsParkinson DiseasePatternPeptide Sequence DeterminationPrion DiseasesPrionsProceduresProteinsResearchResolutionRestRoentgen RaysScreening procedureSeedsSolidStructural ProteinStructureTherapeuticUnited States National Institutes of HealthVertebral columnWorkYeastsamyloid structurebasebeta pleated sheetnovelprogramsprotein aggregationstructural biologysynucleintau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aggregation of proteins in Alzheimer's, Parkinson's, prion diseases, Huntington's, and other amyloid-like diseases will be illuminated by methods of structural and computational biology. Background research by microcrystallography has shown that the fundamental structural unit of amyloid-like fibrils is a set of beta sheets, in which the amino acid sidechains of neighboring sheets intermesh, in what is termed a steric zipper. The steric zipper interface between the faces of the sheets is completely dry. The protein segments that form the sheets are as short as 4-8 residues in length, stacking either in parallel or antiparallel to grow a fibril, but the segments can be longer and some proteins contain several such segments. To learn the structures of amyloid fibrils from disease-associated proteins, the same methods of microcrystallography will be applied to microcrystals grown from short segments of the A? and Tau proteins of Alzheimer's disease, from the PrP protein of the prion diseases, from ?-synuclein of Parkinson's disease, and from proteins involved in ALS and diabetes type 2. To learn what happens during fibril formation to the rest of the protein, structural studies will also be conducted on larger segments and entire fibril-forming proteins, using novel methods of crystal screening and microcrystallography. Preliminary work shows that computational energetics can identify which segments from proteins are those that are fibril-forming and can be grown into microcrystals, suitable for structural determination. This procedure is based on the 3D Profile method for finding sequences that fit a given fold (in this case the steric zipper), using energy functions. The procedure will be extended and applied to amyloids. Once a segment has been discovered which forms fibrils, and its structure has been determined by crystallography as belonging to the steric-zipper type of architecture, the connection between the segment and fibrils of the full protein can be assessed by whether the segment can seed the full protein into fibrils. Further proof of the connection of the segment and fibrils of the full protein can be obtained by mutating residues in the protein that correspond to residues of the segment, and looking for diminished fibrillization. These structures, derived by novel methods of microcrystallography, are the first high-resolution (up to 0.85 A resolution), fully refined atomic structures for the amyloid state. They show that there are at least 4 basic patterns for the steric zipper spines of amyloid fibrils, and perhaps up to 7 such patterns. These structures offer a solid foundation on which to devise diagnostics and therapeutics for these devastating neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10370874
-
项目类别:
-
资助金额:$106.84万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10544785
-
项目类别:
-
资助金额:$119.25万
-
财政年份:2022
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10209753
-
项目类别:
-
资助金额:$156.98万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10657390
-
项目类别:
-
资助金额:$155.45万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Towards Treatment of Alzheimer’s Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
-
批准号:10330046
-
项目类别:
-
资助金额:$107.56万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias
-
批准号:10436894
-
项目类别:
-
资助金额:$154.49万
-
财政年份:2021
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10155527
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10641815
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
TRD1: Dedicated sample preparation for MicroED
-
批准号:10460922
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2020
-
负责人:DAVID EISENBERG
-
依托单位:
Structure and Inhibition of Amyloid in Alzheimer's Disease
-
批准号:9194224
-
项目类别:
-
资助金额:$377.99万
-
财政年份:2016
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9428606
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:9334041
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8752398
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
Development of inhibitors for systemic amyloid diseases
-
批准号:8916013
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2014
-
负责人:DAVID EISENBERG
-
依托单位:
PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE
-
批准号:8361684
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MYCOBACTERIUM TUBERCULOSIS RV3019C-RV3020C ESX COMPLEX
-
批准号:8361683
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
TRUNCATED ALPHAA AND ALPHAB CRYSTALLINS
-
批准号:8361687
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
?2-MICROGLOBULIN
-
批准号:8361688
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2011
-
负责人:DAVID EISENBERG
-
依托单位:
MOLECULAR MECHANISMS FOR PROTEIN-ENCODED INHERITANCE
-
批准号:8169290
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
STRUCTURE/ACTIVITY OF A MEMBER OF THE VAPBC FAMILY OF TOXIN ANTITOXIN SYSTEMS
-
批准号:8169257
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2010
-
负责人:DAVID EISENBERG
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: